Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Cut to “Sell” at Wall Street Zen

Wall Street Zen downgraded shares of Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) from a hold rating to a sell rating in a research report released on Saturday.

Separately, Weiss Ratings started coverage on Inspira Technologies OXY B.H.N. in a research report on Wednesday, May 27th. They issued a “sell (e+)” rating on the stock. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

Inspira Technologies OXY B.H.N. Trading Down 1.0%

NASDAQ:QTEX opened at $1.04 on Friday. Inspira Technologies OXY B.H.N. has a 12 month low of $0.28 and a 12 month high of $3.85. The business’s 50 day moving average price is $1.45. The company has a quick ratio of 1.30, a current ratio of 1.56 and a debt-to-equity ratio of 0.08.

Inspira Technologies OXY B.H.N. announced that its Board of Directors has approved a share buyback plan on Monday, June 22nd that allows the company to repurchase 2,000,000,000,000 shares. This repurchase authorization allows the company to repurchase up to 5.6% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.

Inspira Technologies OXY B.H.N. Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.